HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF006 | 2021 | 3812 | 4327 | 88.1% | |
| HF006 | 2022 | 4731 | 4978 | 95.0% | |
| HF006 | 2023 | 5922 | 6247 | 94.8% |
